Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1993 May;48(5):470–473. doi: 10.1136/thx.48.5.470

Do bronchodilators adversely affect the prognosis of bronchial hyperresponsiveness?

C P van Schayck, C L van Herwaarden
PMCID: PMC464495  PMID: 8322230

Full text

PDF
470

Images in this article

470Image
on p.470

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvidsson P., Larsson S., Löfdahl C. G., Melander B., Svedmyr N., Wåhlander L. Inhaled formoterol during one year in asthma: a comparison with salbutamol. Eur Respir J. 1991 Nov;4(10):1168–1173. [PubMed] [Google Scholar]
  2. Arvidsson P., Larsson S., Löfdahl C. G., Melander B., Wåhlander L., Svedmyr N. Formoterol, a new long-acting bronchodilator for inhalation. Eur Respir J. 1989 Apr;2(4):325–330. [PubMed] [Google Scholar]
  3. Barnes P. J. Effect of corticosteroids on airway hyperresponsiveness. Am Rev Respir Dis. 1990 Feb;141(2 Pt 2):S70–S76. [PubMed] [Google Scholar]
  4. Bel E. H., Timmers M. C., Hermans J., Dijkman J. H., Sterk P. J. The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. Am Rev Respir Dis. 1990 Jan;141(1):21–28. doi: 10.1164/ajrccm/141.1.21. [DOI] [PubMed] [Google Scholar]
  5. Burrows B., Lebowitz M. D. The beta-agonist dilemma. N Engl J Med. 1992 Feb 20;326(8):560–561. doi: 10.1056/NEJM199202203260809. [DOI] [PubMed] [Google Scholar]
  6. Cheung D., Timmers M. C., Zwinderman A. H., Bel E. H., Dijkman J. H., Sterk P. J. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med. 1992 Oct 22;327(17):1198–1203. doi: 10.1056/NEJM199210223271703. [DOI] [PubMed] [Google Scholar]
  7. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977 May;7(3):235–243. doi: 10.1111/j.1365-2222.1977.tb01448.x. [DOI] [PubMed] [Google Scholar]
  8. Crane J., Pearce N., Flatt A., Burgess C., Jackson R., Kwong T., Ball M., Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet. 1989 Apr 29;1(8644):917–922. doi: 10.1016/s0140-6736(89)92505-1. [DOI] [PubMed] [Google Scholar]
  9. Dompeling E., van Schayck C. P., van Grunsven P. M., van Herwaarden C. L., Akkermans R., Molema J., Folgering H., van Weel C. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med. 1993 May 15;118(10):770–778. doi: 10.7326/0003-4819-118-10-199305150-00003. [DOI] [PubMed] [Google Scholar]
  10. Dugas B., Lagente V., Mencia-Huerta J. M., Braquet P. Pharmacological modulation of the expression of the low affinity IgE receptor. Monogr Allergy. 1991;29:76–93. [PubMed] [Google Scholar]
  11. Dutoit J. I., Salome C. M., Woolcock A. J. Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not. Am Rev Respir Dis. 1987 Nov;136(5):1174–1178. doi: 10.1164/ajrccm/136.5.1174. [DOI] [PubMed] [Google Scholar]
  12. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Reinikainen K., Selroos O. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991 Aug 8;325(6):388–392. doi: 10.1056/NEJM199108083250603. [DOI] [PubMed] [Google Scholar]
  13. Juniper E. F., Kline P. A., Vanzieleghem M. A., Ramsdale E. H., O'Byrne P. M., Hargreave F. E. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990 Oct;142(4):832–836. doi: 10.1164/ajrccm/142.4.832. [DOI] [PubMed] [Google Scholar]
  14. Kerrebijn K. F., van Essen-Zandvliet E. E., Neijens H. J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987 Apr;79(4):653–659. doi: 10.1016/s0091-6749(87)80163-x. [DOI] [PubMed] [Google Scholar]
  15. Kerstjens H. A., Brand P. L., Hughes M. D., Robinson N. J., Postma D. S., Sluiter H. J., Bleecker E. R., Dekhuijzen P. N., de Jong P. M., Mengelers H. J. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. N Engl J Med. 1992 Nov 12;327(20):1413–1419. doi: 10.1056/NEJM199211123272003. [DOI] [PubMed] [Google Scholar]
  16. Kraan J., Koëter G. H., vd Mark T. W., Sluiter H. J., de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol. 1985 Oct;76(4):628–636. doi: 10.1016/0091-6749(85)90786-9. [DOI] [PubMed] [Google Scholar]
  17. Mitchell E. A. Is current treatment increasing asthma mortality and morbidity? Thorax. 1989 Feb;44(2):81–84. doi: 10.1136/thx.44.2.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Molema J., van Herwaarden C. L., Folgering H. T. Effects of long-term treatment with inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in patients with allergic asthma. Eur Respir J. 1989 Apr;2(4):308–316. [PubMed] [Google Scholar]
  19. Page C. P. One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists. Lancet. 1991 Mar 23;337(8743):717–720. doi: 10.1016/0140-6736(91)90289-2. [DOI] [PubMed] [Google Scholar]
  20. Raes M., Mulder P., Kerrebijn K. F. Long-term effect of ipratropium bromide and fenoterol on the bronchial hyperresponsiveness to histamine in children with asthma. J Allergy Clin Immunol. 1989 Dec;84(6 Pt 1):874–879. doi: 10.1016/0091-6749(89)90382-5. [DOI] [PubMed] [Google Scholar]
  21. Schuster A., Kozlik R., Reinhardt D. Influence of short- and long-term inhalation of salbutamol on lung function and beta 2-adrenoceptors of mononuclear blood cells in asthmatic children. Eur J Pediatr. 1991 Jan;150(3):209–213. doi: 10.1007/BF01963569. [DOI] [PubMed] [Google Scholar]
  22. Sears M. R., Taylor D. R., Print C. G., Lake D. C., Li Q. Q., Flannery E. M., Yates D. M., Lucas M. K., Herbison G. P. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990 Dec 8;336(8728):1391–1396. doi: 10.1016/0140-6736(90)93098-a. [DOI] [PubMed] [Google Scholar]
  23. Spitzer W. O., Suissa S., Ernst P., Horwitz R. I., Habbick B., Cockcroft D., Boivin J. F., McNutt M., Buist A. S., Rebuck A. S. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20;326(8):501–506. doi: 10.1056/NEJM199202203260801. [DOI] [PubMed] [Google Scholar]
  24. Svendsen U. G., Frølund L., Madsen F., Nielsen N. H. A comparison of the effects of nedocromil sodium and beclomethasone dipropionate on pulmonary function, symptoms, and bronchial responsiveness in patients with asthma. J Allergy Clin Immunol. 1989 Aug;84(2):224–231. doi: 10.1016/0091-6749(89)90329-1. [DOI] [PubMed] [Google Scholar]
  25. Twentyman O. P., Finnerty J. P., Harris A., Palmer J., Holgate S. T. Protection against allergen-induced asthma by salmeterol. Lancet. 1990 Dec 1;336(8727):1338–1342. doi: 10.1016/0140-6736(90)92894-n. [DOI] [PubMed] [Google Scholar]
  26. Ullman A., Hedner J., Svedmyr N. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. Am Rev Respir Dis. 1990 Sep;142(3):571–575. doi: 10.1164/ajrccm/142.3.571. [DOI] [PubMed] [Google Scholar]
  27. Vathenen A. S., Knox A. J., Higgins B. G., Britton J. R., Tattersfield A. E. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet. 1988 Mar 12;1(8585):554–558. doi: 10.1016/s0140-6736(88)91352-9. [DOI] [PubMed] [Google Scholar]
  28. Waalkens H. J., Gerritsen J., Koëter G. H., Krouwels F. H., van Aalderen W. M., Knol K. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow. Thorax. 1991 Jul;46(7):499–503. doi: 10.1136/thx.46.7.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van Schayck C. P., Dompeling E., van Herwaarden C. L., Folgering H., Verbeek A. L., van der Hoogen H. J., van Weel C. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. BMJ. 1991 Dec 7;303(6815):1426–1431. doi: 10.1136/bmj.303.6815.1426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. van Schayck C. P., Folgering H., den Otter J. J., Tirimanna P., van Weel C. Does the continuous use of bronchodilators mask the progression of asthma or chronic bronchitis? Fam Pract. 1992 Dec;9(4):397–404. doi: 10.1093/fampra/9.4.397. [DOI] [PubMed] [Google Scholar]
  31. van Schayck C. P., Graafsma S. J., Visch M. B., Dompeling E., van Weel C., van Herwaarden C. L. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol. 1990 Nov;86(5):793–800. doi: 10.1016/s0091-6749(05)80185-x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES